We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| C4x Discovery Holdings Plc | C4XD | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 12.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.00 | 12.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 11/4/2024 06:43 by takeiteasy Our large holder here has another minnow biotech firm ETX where he has a significant stake and he is supporting their recent announcement to delist from AIM , although the carrot is put down that they aspire to a nasdaq listing in the future. Their market cap is now 70m.We would have a mile to go to get our cap up to the required levels but it shows these investors are a least aware of wider options to pursue etc etc.. dyor |
Posted at 05/4/2024 08:09 by takeiteasy If you read the meeting notes from the firm, they say that there will be a definite dealing facility for 12 months and no guarantee afterwards. The attitude to small investors is next to appalling - why did they ever try to run this as a public company in the first place.I sincerely hope within that period someone else who can provide longer term funds and a business straetegy to turn this into a long term profitable business model steps in...I suspect our largest holder is a clever business man and he has some sort of plan in his head about where to take this business....fingers crossed as they say... The issue in holding these shares in the SIPP is at valuation points when you vest the SIPP as the provider needs to validate portfolio value for tax reasons as the PDF confirms - while we have the matched bargain facility there is a daily trail of dealt prices. After that it may get messy....so 12 months is my likely time horizon here one way or the other... dyor and no advice intended etc |
Posted at 29/2/2024 15:39 by takeiteasy DM3, spot on article - and it reminds me the extra challenges we have being such a niche part of the biotech space which again makes it harder for new investors to resonate with us compared to say drugs for weight loss etc.Duty on the firm to be bold and broaden their networks with senior industry players and market their message around. |
Posted at 23/2/2024 13:38 by takeiteasy A serious seller dumping atm- is this one of the larger holders...we simply do not know and wait on a large holdings note if this applies.There does not seem to me to be much valuation interest in companies who fail to have assets in phases 1-3 etc. I am happy to be corrected but big pharma seem to want ready to go products in the main and will pay up. Clearly we do have AZ in background development mode with our product but this is not whetting investor appetite atm. dyor |
Posted at 23/1/2024 12:40 by takeiteasy perhaps we simply need a fresh set of long term investors from the US who have a good grasp of Biotech valuations and can provide more liquidity, this may work via a US listing. Seems to have done the trick for my other biotech holding which also has our large holder here as a major investor so he would understand the process perhaps.Perhaps something that can be raised at the next AGM? |
Posted at 13/4/2022 16:58 by t0pgrader In case anyone missed it, the INDIVIOR update on Phase 1 SAD of Orexin 1 Inhibitor INDV 2000) was published Feb 16 in the Q4 21 results. The report says Phase 1 MAD is on clinical hold at the instruction of the FDA based on "nonclinical findings from another similar development programme not sponsored by Indivior". However, "major progress" made on formulation and chemical development |
Posted at 03/2/2022 07:41 by livewireplus RNS: Grant of Options and Directors Dealing |
Posted at 24/1/2022 18:04 by alloa2003 Savvy investors will start picking up cheap stock now - whoever "managed" this sale over the last week or so doesnt have a clue. They have smashed a share price and set the rumour mill going again. |
Posted at 13/12/2021 07:45 by alloa2003 Good solid results and plenty of little nuggets in there to keep investors interested but not the biggy I was personally expecting. Interesting to see they have made plans to conserve cash in the event that trials are extended, etc and they wont need to raise any more funds. I think C4XD is on the verge of becoming self-funding which is a massive step forward and should remove the previously constant threat of a fund raising.Interesting to see this element of the announcement about the previous fund raising:- Successful £15.0 million fundraise (before expenses) with a total of 107,142,858 Placing Shares and 99,169,286 Warrants issued to new and existing shareholders I believe the warrant strike price is 29p so if ever they needed additional funding these warrants could be exercised by, I would guess, mostly institutional shareholders - circa £30m. Dilutive but a useful drop back to have if they ever needed cash for any reason. All in all, steady as she goes I think and we await further developments within some of the very interesting historic and new areas mentioned. |
Posted at 07/11/2021 14:45 by alloa2003 Of course they can but do you often buy shares only traded on foreign markets? Do you think US investors are even aware that C4XD exists? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
